The following amendment has been made to the Notification of Major Interest in Shares announcement released on 28 November 2016 at 12:00 under RNS No 3164Q.
The chain of controlled undertakings detailed in Section 9 has been corrected.
All other details remain unchanged. The full amended text is shown below.
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
||||
|
|
|||
1. Identity of the issuer or the underlying issuer |
Futura Medical plc |
|||
2 Reason for the notification (please tick the appropriate box or boxes): |
||||
An acquisition or disposal of voting rights |
|
|||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
|||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
|||
An event changing the breakdown of voting rights |
X |
|||
Other (please specify): |
Aggregation of holdings |
|
||
3. Full name of person(s) subject to the |
R.A. Lamb |
|||
4. Full name of shareholder(s) |
- |
|||
5. Date of the transaction and date on |
22/11/16 |
|||
6. Date on which issuer notified: |
28/11/16 |
|||
7. Threshold(s) that is/are crossed or |
8% |
|||
8. Notified details: |
|||||||||||||||||
A: Voting rights attached to shares |
|||||||||||||||||
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
|||||||||||||||
Number |
Number |
Number |
Number of voting |
% of voting rights |
|||||||||||||
Direct |
Indirect |
Direct |
Indirect |
Direct |
Indirect |
||||||||||||
Ordinary Shares
GB0033278473 |
8,779,110 |
8,779,110 |
5,330,400 |
3,448,710 |
5,330,400 |
3,448,710 |
4.44% |
2.87% |
|||||||||
|
|||||||||||||||||
|
|||||||||||||||||
B: Qualifying Financial Instruments |
|||||||||||||||||
Resulting situation after the triggering transaction |
|||||||||||||||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting |
|||||||||||||
n/a |
n/a |
n/a |
n/a |
n/a |
|||||||||||||
|
|||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments |
|||||||||||||||||
Resulting situation after the triggering transaction |
|||||||||||||||||
Type of financial |
Exercise price |
Expiration date |
Exercise/ |
Number of voting rights instrument refers to
|
% of voting rights
|
||||||||||||
|
|
|
|
|
Nominal |
Delta |
|||||||||||
|
|
||||||||||||||||
|
|||||||||||||||||
Total (A+B+C) |
|||||||||||||||||
Number of voting rights |
Percentage of voting rights |
||||||||||||||||
8,779,110 |
7.31% |
||||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the |
|||
R. A Lamb |
5,330,400 |
4.44% |
|
|
|
|
|
Shares held by others but connected to R. A Lamb |
3,448,710 |
2.87% |
|
|
|||
Proxy Voting: |
|||
10. Name of the proxy holder: |
n/a |
||
11. Number of voting rights proxy holder will cease to hold: |
n/a |
||
12. Date on which proxy holder will cease to hold voting rights: |
n/a |
||
|
|||
|
|
||
14. Contact name: |
Derek Martin |
||
15. Contact telephone number: |
01483 685670 |
||